CVS HEALTH CORP holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 73,459,122 | $4,976,855,516 | 2.84% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2025 |
| June 30, 2025 | 73,288,766 | $5,055,459,079 | 2.84% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 13, 2025 |
| Sept. 30, 2025 | 73,176,586 | $5,516,782,819 | 2.98% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 13, 2025 |
| Dec. 31, 2025 | 62,509,988 | $4,960,792,648 | 2.68% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 51,780,116 | $3,718,847,931 | 2.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2026 |
| June 30, 2026 | 50,012,765 | $5,173,820,539 | 2.71% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 13, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
CVS HEALTH Corp · SC 13G/A · Event June 30, 2026 · Filed Aug. 13, 2026
| Reporting person | Reported shares | % of security class | Group box |
|---|---|---|---|
| Dodge & Cox | 50,012,765 | 3.9% | Unavailable |
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.